Frontiers in Immunology APC and Open Access: What the CHF 3,150 Fee Gets You
Frontiers in Immunology APCs are CHF 3,150 for A-type and CHF 2,500 for B-type articles. Compare tiers, support paths, and total cost.
Readiness scan
APC budgeted? See what Frontiers in Immunology reviewers are likely to push back on.
The fee is one decision. Getting through review is the harder one. Run the Free Readiness Scan with Frontiers in Immunology as your target to see desk-rejection risk, likely reviewer concerns, and journal fit.
Frontiers in Immunology publishing costs and open access options
APC is one cost. Funder mandates, institutional agreements, and access route timing all shape what you actually pay.
What shapes what you pay
- Frontiers in Immunology offers open access publishing. Check whether your institution has a read-and-publish agreement.
- Funder mandates (NIH, Wellcome, UKRI) may require immediate OA, verify compliance before choosing a subscription route.
- Accepted authors typically have 48-72 hours to choose their access route before proofs begin.
When OA is worth the cost
- When your funder or institution requires it, non-compliance can affect future funding.
- When your topic benefits from broad immediate access beyond institutional subscribers.
- Open access can widen practical access, but it does not change whether the journal fits the manuscript.
Quick answer: Frontiers currently lists the Frontiers in Immunology APC at CHF 3,150 for A-type articles, CHF 2,500 for B-type articles, and zero for C-type articles. Confirm the article type, section fit, institutional coverage, and support eligibility before treating the headline fee as the amount your team will pay.
Evidence basis: We verified the Frontiers in Immunology publishing-fees page, journal page, and Frontiers fee policy on September 4, 2026. Frontiers controls current prices and eligibility. The cost decision map is Manusights interpretation.
Cost question | Current source-backed answer | Decision risk |
|---|---|---|
Which price band applies? | A-type CHF 3,150; B-type CHF 2,500; C-type zero | Choosing an article type to chase a lower fee |
Is the journal subscription based? | No; it uses a gold open-access model | Confusing reader access with author cost |
Can support reduce the invoice? | Partnerships or fee support may apply | Assuming eligibility before confirmation |
Is the APC worth paying? | Only after section, article type, evidence, and funding fit are clear | Letting sunk editing effort decide journal fit |
Evaluate the full publication cost
Check the live article-type price, institutional partnership, funder rules, taxes, currency handling, and internal approval path together. A list price is not yet a project budget, and a lower article-type band is not permission to misclassify the manuscript.
Cost risks to resolve
Do not assume a discount applies until Frontiers or the institution confirms it. Do not describe a gold open-access journal as free to publish, and do not let a paid APC substitute for section fit, evidence completeness, or an honest article type.
Complete the funding check
Record the article type, listed CHF amount, support route, confirmation owner, and payment deadline. Then make the submit decision from scientific fit and evidence quality, with cost as one constraint rather than the journal-selection rule.
Check three paths separately: whether author location, including residence in low-income countries, is considered in individual support; whether an institutional partnership covers part or all of the charge; and whether a financial-need request can receive case-by-case fee support. None is automatic, and the live Frontiers decision controls.
Frontiers in Immunology APC at a glance
Item | Current position |
|---|---|
Journal model | Fully open access |
A-type APC | CHF 3,150 |
B-type APC | CHF 2,500 |
C-type APC | 0 |
Subscription route | None |
Institutional partnership support | Full or partial support possible |
Fee-support program | Discounts possible for eligible lower-income countries |
Current journal-page impact factor | 7.0 |
CiteScore | 11.3 |
SJR | 1.941 |
SNIP | 1.259 |
If you want to know whether the manuscript is in the right section and article type before you worry about the APC, run a Frontiers in Immunology submission readiness check.
If the real issue is whether the paper is broad enough for the journal's section-led model, use the Frontiers in Immunology scope and section-fit check.
What Frontiers currently says
Frontiers is unusually explicit on pricing. Its live publishing-fees page for Frontiers in Immunology states:
- A-type articles: CHF 3,150
- B-type articles: CHF 2,500
- C-type articles: 0
It also defines the buckets:
- A-type: Original Research, Systematic Review, Methods, Review, Hypothesis and Theory, Clinical Trial, Classification, Technology and Code, Study Protocol
- B-type: Mini Review, Perspective, Case Report, Brief Research Report, General Commentary, Opinion
- C-type: Correction, Editorial, Retraction
That article-type split is the first thing many authors miss. Frontiers in Immunology is not a one-price journal.
The journal page also adds two useful current signals:
- current JIF 7
- current published decision signal of 77 days
Why the APC question depends on article type and section fit
Frontiers in Immunology is a broad, section-led journal. The APC only makes sense once those two editorial questions are settled:
- Which article type is this really?
- Which specialty section truly owns the paper?
That matters because authors sometimes overpay by forcing a paper into an A-type framing when the work is honestly a shorter B-type contribution. The reverse problem also happens: teams submit a thin paper as a full Original Research article and then discover they are paying the higher rate for a manuscript that still looks underpowered.
Metrics context behind the APC
Metric | Current figure | Why it matters with the APC |
|---|---|---|
JIF | 7 | Solid Q1 immunology visibility |
CiteScore | 10.8 | Stronger four-year citation picture than the JIF alone |
SJR | 1.941 | Prestige-weighted Scopus influence is comfortably credible |
SNIP | 1.259 | The field-normalized signal remains positive |
Category rank | 32/183 | The journal stays in the upper tier of broad immunology |
Editorial model | Section-led, large-volume OA | The journal trades scarcity for breadth and speed |
These numbers tell the honest story. Frontiers in Immunology is a real, visible immunology journal. It is not a prestige substitute for the most selective immunology brands.
Long-run citation context
Year | JIF |
|---|---|
2017 | 5.5 |
2018 | 4.7 |
2019 | 5.1 |
2020 | 7.6 |
2021 | 8.8 |
2022 | 7.3 |
2023 | 6.4 |
2024 | 5.9 |
The year-over-year read is mildly negative. Frontiers in Immunology is down from 6.4 in 2023 to 5.9 in 2024. That does not invalidate the journal. It does mean authors should read the APC honestly: this is a broad, credible Q1 immunology venue, but it is not moving toward a higher-selectivity prestige tier.
Fee support, partnerships, and what authors actually pay
Frontiers' current fee pages make two support paths explicit:
- institutional partnerships may provide full or partial APC support
- authors from World Bank low or lower-middle income countries may be eligible for discounts
- authors in low-income countries can have location considered through individual support, while every request remains case by case
- a corresponding author's institutional partnership can provide full or partial coverage under its agreement
- an individual application can document financial need; Frontiers reviews that request case by case and support is not guaranteed
Frontiers also says it waived more than USD 25 million across 2023 and 2024 through its fee-support program.
That means the actual number paid can change because of:
- a Frontiers institutional partnership
- country-based fee support
- funder reimbursement or institutional OA funds
- the article-type band chosen at submission
The safe planning rule is:
- budget against CHF 3,150 unless you know the paper is B-type
- then confirm whether support reduces it
What we see in pre-submission review work with Frontiers in Immunology manuscripts
For manuscripts targeting Frontiers in Immunology, the APC is easiest to justify when the section fit and article type are both honest.
The paper is often placed in the wrong section. That slows review and weakens the case for paying a fairly substantial APC.
Authors sometimes inflate the article type. A shorter contribution with limited mechanistic depth may belong in a Brief Research Report or Mini Review lane rather than a full A-type article.
Broad scope does not mean no editorial standard. Frontiers in Immunology still expects a real immunology contribution, clear methodology, and enough maturity for collaborative review.
That is why the best way to save money here is often to choose the right article type early rather than argue about the invoice late.
Readiness check
Run the scan while the topic is in front of you.
See score, top issues, and journal-fit signals before you submit.
How Frontiers in Immunology compares with nearby options
Journal | APC structure | Metric profile | Practical fit |
|---|---|---|---|
Frontiers in Immunology | Fully OA, CHF 3,150 A-type or CHF 2,500 B-type | IF 5.9, CiteScore 10.8 | Broad section-led immunology |
Journal of Immunology | Hybrid society route | Lower headline metrics, narrower field identity | Better for authors who want the AAI lane |
Journal of Experimental Medicine | Higher-tier selective hybrid route | Stronger prestige signal | Better only for a clearly stronger story |
PLOS ONE | Cheaper fully OA broad route | Lower field specificity | Better when the work is not strongly immunology-owned |
Nature Immunology / Immunity | Much higher APC and much higher bar | Selective flagship tier | Better only for much stronger novelty |
The comparison that matters most is not just price. It is whether you want a broad OA immunology section model or a narrower society/specialty journal.
Practical verdict
Frontiers in Immunology is a fully OA journal, so the APC is a real part of the decision. The current numbers are:
- CHF 3,150 for A-type articles
- CHF 2,500 for B-type articles
- 0 for C-type items
That makes the best decision sequence:
- identify the honest article type
- confirm the right specialty section
- check whether institutional or country-based support reduces the APC
Current article-type APC tiers
Article type category | Current APC | Decision note |
|---|---|---|
A-type | CHF 3,150 | Confirm the selected article type and specialty section on the live fee page |
B-type | CHF 2,500 | Do not choose a shorter category merely to reduce cost |
C-type | CHF 0 | Limited formats; eligibility depends on the journal's article-type rules |
APC trend guardrail
Frontiers publishes the current price by journal and article type, but the pages reviewed for this update do not provide a verified year-by-year historical APC series for Frontiers in Immunology. Do not manufacture a trend from cached snippets. Recheck the official pricing page on the day the funding decision is made.
Fee support and institutional agreements
- Country and location route: Frontiers says individual fee-support review may consider author location and available funds; eligibility is not guaranteed.
- Institutional partnership: check whether the corresponding author's university, library, funder, or consortium has a Frontiers institutional agreement with partial or full coverage.
- Financial-need route: the individual fee support application asks about funding constraints and financial need and should be filed before acceptance, preferably before submission.
These paths are separate checks, not stackable promises. Frontiers states that individual support is assessed case by case and depends on available funds.
Total cost and hidden-cost check
Calculate the invoice from the APC after any approved discount, then add VAT or local tax where applicable. Do not count optional language editing, cover art, reprints, or other third-party services as part of the listed APC. Confirm who pays, the invoicing entity, currency conversion, tax status, payment timing, and what happens if fee support is smaller than expected. Before paying, reconcile the manuscript title, abstract, methods, results, figures, data, and declarations with the selected article type. The cost map is Manusights editorial judgment and cannot predict acceptance.
See the Frontiers in Immunology journal hub before treating price as the only route decision.
Submit if / Think twice if
Submit and consider the APC worthwhile if:
- the paper clearly fits a Frontiers in Immunology section
- the chosen article type is honest
- the work benefits from broad OA distribution across immunology
- institutional or funder support covers most of the APC
Think twice if:
- the article type is being stretched just to fit a preferred journal
- the section ownership is fuzzy
- the APC would be personal out-of-pocket spend without a clear audience payoff
- the work is either much stronger than this lane or much thinner than the selected article type
Frequently asked questions
Frontiers currently lists Frontiers in Immunology at CHF 3,150 for A-type articles and CHF 2,500 for B-type articles. Corrections and editorials in the C-type bucket carry no APC.
Yes. Frontiers in Immunology is a gold open-access journal, so there is no subscription route. All accepted articles publish open access and APC support has to come from the author, institution, or a Frontiers support mechanism.
Yes. Frontiers states that institutional partnerships may provide full or partial APC support, and authors from World Bank low or lower-middle income countries may be eligible for discounts through the Frontiers support program.
Because Frontiers prices article types differently. A full Original Research or Review article sits in the A-type band, while Mini Reviews, Brief Research Reports, Opinions, and some other shorter formats sit in the cheaper B-type band.
It is easiest to justify when the paper fits the journal's broad section-led immunology model, the article type is chosen honestly, and institutional or funder support covers most of the cost.
Sources
Free guide
The list price is rarely the price you pay.
Waivers, funder agreements and institutional deals move it, and the deadline for most of them is submission, after which there is no appeal. Every figure in the guide was read off the publisher or funder page that sets it, on the date shown, and each one is linked at the end.
Before you upload
Want the full picture on Frontiers in Immunology?
Scope, selectivity, what editors want, common rejection reasons, and submission context, all in one place.
These pages attract evaluation intent more than upload-ready intent.
Private API processing. Your manuscript is not used to train models.
Put the guidance to work
Build a journal decision from more than one signal.
Use comparison data as a starting point, then confirm the live source that governs the actual submission decision.
Where to go next
Start here
Same journal, next question
- Frontiers in Immunology Submission Guide (2026)
- Is Frontiers in Immunology a Good Journal? The High-Volume OA Question
- Frontiers in Immunology Impact Factor 2026: Ranking, Quartile & What It Means
- Frontiers in Immunology Cover Letter: What Editors Actually Need to See
- Frontiers in Immunology 'Under Review': What the Status Means
- Frontiers in Immunology Formatting Requirements: Complete Author Guide